Neurofilament Light Chain (NfL) in Blood—A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke

Neurofilament Light Chain (NfL) in Blood—A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke

Increased sensitivity of methods assessing the levels of neurofilament light chain (NfL), a neuron-specific intermediate filament protein, in human plasma or serum, has in recent years led to a number of studies addressing the utility of monitoring NfL in the blood of stroke patients. In this review...

Full description

Bibliographic Details
Main Authors: Milos Pekny, Ulrika Wilhelmsson, Anna Stokowska, Turgut Tatlisumak, Katarina Jood, Marcela Pekna
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cells
Subjects:
neurofilament light chain
intermediate filament proteins
nanofilament proteins
biomarkers
stroke
cerebrovascular disease
Online Access:https://www.mdpi.com/2073-4409/10/6/1537

Internet

https://www.mdpi.com/2073-4409/10/6/1537

Similar Items